Medical Forum / General / Dentistry / June 2007
Dead Monkeys Don't Lie (about mercury)
|
|
Thread rating:  |
jay - 08 Jun 2007 16:26 GMT This article was published almost 2 decades ago in Exp Mol Pathol. 1990 Jun;52(3):291-9. Why are Dentists still using mercury based amalgams?
Traces of Mercury in Organs from Primates with Amalgam Fillings. Danscher G, Hørsted-Bindslev P, Rungby J. Department of Neurobiology, University of Aarhus, Denmark.
In order to trace possible accumulations of mercury, three vervet monkeys received occlusal amalgam fillings, three others maxillary bone implants of amalgam, and three untreated monkeys served as controls. One year later all animals were sacrificed by transcardial perfusion with glutaraldehyde. Tissue sections from different organs were subjected to silver amplification by autometallography and analyzed at light and electron microscopical levels. It was found that amalgam fillings (total, 0.7-1.2 g) caused deposition of mercury in the following tissues: spinal ganglia, anterior pituitary, adrenal, medulla, liver, kidneys, lungs, and intestinal lymph glands. In monkeys with maxillary silver amalgam implants (total, 0.1-0.3 g), mercury was found in the same organs except for liver, lungs, and intestinal lymph glands. Organs from the three control animals were devoid of precipitate. To evaluate whether silver released from the corroding amalgam fillings added to the staining pattern, tissue sections were exposed to potassium cyanide prior to being autometallographically developed. This treatment removes all traces of silver, leaving mercury sulfide accumulation untouched. By comparing sections that had been exposed to cyanide with untreated parallels no difference was seen in the pattern confirming that mercury was the only catalyst present in the tissue. These results strongly support what has been suggested previously that dental fillings in primates cause absorption of mercury released from amalgam fillings through lungs and intestinal tract, and that depending on exposure mercury is distributed to most organs and will eventually be found in the central nervous system. The present data also show that silver released from the corroding filling is not absorbed.
PMID: 2115006 [PubMed - indexed for MEDLINE]
Jan Drew - 12 Jun 2007 09:16 GMT This article was published almost 2 decades ago in Exp Mol Pathol. 1990 Jun;52(3):291-9. Why are Dentists still using mercury based amalgams?
Traces of Mercury in Organs from Primates with Amalgam Fillings. Danscher G, Hørsted-Bindslev P, Rungby J. Department of Neurobiology, University of Aarhus, Denmark.
In order to trace possible accumulations of mercury, three vervet monkeys received occlusal amalgam fillings, three others maxillary bone implants of amalgam, and three untreated monkeys served as controls. One year later all animals were sacrificed by transcardial perfusion with glutaraldehyde. Tissue sections from different organs were subjected to silver amplification by autometallography and analyzed at light and electron microscopical levels. It was found that amalgam fillings (total, 0.7-1.2 g) caused deposition of mercury in the following tissues: spinal ganglia, anterior pituitary, adrenal, medulla, liver, kidneys, lungs, and intestinal lymph glands. In monkeys with maxillary silver amalgam implants (total, 0.1-0.3 g), mercury was found in the same organs except for liver, lungs, and intestinal lymph glands. Organs from the three control animals were devoid of precipitate. To evaluate whether silver released from the corroding amalgam fillings added to the staining pattern, tissue sections were exposed to potassium cyanide prior to being autometallographically developed. This treatment removes all traces of silver, leaving mercury sulfide accumulation untouched. By comparing sections that had been exposed to cyanide with untreated parallels no difference was seen in the pattern confirming that mercury was the only catalyst present in the tissue. These results strongly support what has been suggested previously that dental fillings in primates cause absorption of mercury released from amalgam fillings through lungs and intestinal tract, and that depending on exposure mercury is distributed to most organs and will eventually be found in the central nervous system. The present data also show that silver released from the corroding filling is not absorbed.
PMID: 2115006 [PubMed - indexed for MEDLINE]
http://groups.google.com/group/sci.med.dentistry/msg/f560aa96975cb8a5?hl=en&
Recently, Caulk Company, manufacturers of Dispersalloy, published the latest Materials Safety Data Sheet (MSDS) and their Direction For Use (DFU) which includes contraindications to the use of dental amalgam. (.http://www.caulk.com/MSDSDFU/DispersDFU.html February 1998)
[no longer available]
I just happen to still have it.
**** the manufacturers are now acknowledging the intrinsic dangers of this material.***** The legal implications of this latest development are far reaching. If you continue to use dental amalgam you may be playing legal roulette with your assets.
Caulk state that dental amalgam should not be used: 1. In proximal or occlusal contact to dissimilar metal restorations. 2. In patients with severe renal deficiency.
3. In patients with known allergies to amalgam.
4. For retrograde or endodontic filling.
5. As a filling material for cast crown.
6. In children 6 and under.
7. In expectant mothers.
The Caulk Co. home page also warns that mercury may be a skin sensitizer, pulmonary sensitizer, nephrotoxin and neurotoxin and, further, cautions that the number of amalgam restorations for one patient should be kept to a minimum.
Caulk has also published the Material Safety Data Sheet (MSDS) for mercury. Of particular importance, are some statements made in "Section VIII - Control Measures, Inhalation, Chronic: Inhalation of mercury vapour over a long period may cause mercurialism, which is characterized by fine tremors and erethism. Tremors may affect the hands first, but may also become evident in the face, arms, and legs. Erethism may be manifested by abnormal shyness, blushing, self consciousness, depression or despondency, resentment of criticism, irritability or excitability, headache, fatigue, and insomnia. In severe cases, hallucinations, loss of memory, and mental deterioration may occur. Concentrations as low as 0.03 mg/m3 have induced psychiatric symptoms in humans. Renal involvement may be indicated by proteinuria, albuminuria, enzymuria, and anuria. Other effects may include salivation, gingivitis, stomatitis, loosening of the teeth, blue lines on the gums, diarrhea, chronic pneumonitis and mild anemia. Repeated exposure to mercury and its compounds may result in sensitisation. Intrauterine exposure may result in tremors and involuntary movements in the infants. Mercury is excreted in breast milk. Paternal reproductive effects and effects on fertility have been reported in male rats following repeated inhalation exposures."
Ivoclar/Vivadent go further in their contraindications. They state that their amalgam is:
1. Not only contraindicated for expectant mothers but also for nursing mothers.
2. Not only contraindicated for patients with severe renal deficiency but for all
patients suffering from any reduced kidney function.
The Australian Dental Association is now in a difficult, if not untenable, position. The prevailing ADA position is that patient exposure to mercury from amalgam dental fillings is medically insignificant. At the same time major amalgam manufacturers are exhibiting public warnings.
All dentists must now acknowledge the contradictions between ADA policy and amalgam manufacturers' public warnings.
Medico-legally, the dentist who ignores manufacturer's public warnings places himself/herself in a precarious position. Dentists are obliged to be familiar with the information provided in MSDS's for the products they use and if patients suffer ill effects from the product being used in a way which is contrary to the manufacturer's directions, then the dentist may be liable for the consequences. In this situation it does not matter what the Australian Dental Association says, as it is the dentist who will be held responsible. You may be interested to know that the American Dental Association has recognised such a possibility and in a recent case petitioned the court to release it from a suit filed jointly against a dentist and the AmDA,. The AmDA claimed that it owed no responsibility for the advice being given. The court granted the petition, which left the dentist, who had relied on AmDA advice, as the sole defendant. It is little comfort that you may be insured.
All dentists must be aware of the potential adverse effects of mercury exposure and must also be attentive to the potential effects in pregnant females and nursing mothers. Before placing another amalgam filling, a dentist might be well advised to establish that the patient has normal kidney function. It is not clear whether taking a medical history will suffice or whether a kidney function test might need to be requested. The galvanic effect created by placing different metals in a mouth with amalgam fillings has the potential to increase mercury release from all amalgam fillings. This also has implications not generally considered when placing stainless steel orthodontic appliances in a patient with amalgam fillings. The use of metal pins with amalgam may need to be reconsidered. If amalgam is contraindicated in a six year old, the next question must surely be - at what age is amalgam safe? The scientific research shows clearly that mercury is toxic to all people, at all levels. The Agency for Toxic Substances and Disease Registry in the USA lists mercury as one of the twenty most hazardous substances to human beings. The ATSDR's current allowable Minimal Risk Levels (MRL) for acute exposure are 0.02 mcgm/m3 and for chronic exposure 0.014 mcgm/m3. Compare this with published research, indicating amalgam mercury vapour concentrations in the mouth, as high as 87.5 mcgm/m3. The absorption rate of inhaled mercury vapour is extremely high, approximately 80% of the inhaled dose, reaching the brain tissue within one blood circulation cycle. The toxic threshold for mercury vapour has never been found. Even the US Environmental Protection Agency has so stated. The existing occupational standards are all specifically declared to be estimates only on the appearance of clinically observable signs and symptoms. The World Health Organisation, in 1991, made it clear that there is NO safe level of mercury vapour and that amalgam represents the greatest source of mercury to the general population.
The spectre of potential liability for adverse effects from dental amalgam is now a reality.
ASOMAT recently made a 4 page submission to the Federal Executive of the Australian Dental Association offering confidential background briefings about the latest research to all Executive members and any other officers or committees. ASOMAT's submission was conciliatory and asked for the lines of communication to be opened so that the ADA could stay informed about ALL the research. Our offer of cooperation was peremptorily rejected.
Any dentist faced with patients wanting the removal of amalgams from their mouths should note that specific protocols exist for the safer removal of amalgam. Unless you are familiar with these protocols, it is not recommended to proceed with the wholesale removal of dental amalgam. You may create more problems than you solve.
It would be appropriate for you to contact your insurer and ask the specific question..." If I use amalgam contrary to the specific warnings and contraindications stated by the manufacturer and my patient suffers effects known to be associated with mercury exposure, will you cover me fully for my legal costs and any damages in the event that the patient sues me? " Whatever the answer, get it in writing!
ASOMAT's concern has always been that dentists and patients be fully informed. We are very worried that the profession is badly prepared to deal with these quickly changing circumstances, especially in light of a recent press conference in Sweden on the 19th February 1998. At that time the Swedish Council for Planning and Coordinating Research, a body commissioned by the Swedish Government to review the literature on amalgams, stated the following.. "Mercury from amalgam may damage the brain, kidneys and the immune system of a great number of people. The effects in foetus and children are of most concern." Those are the conclusions of a report soon to be handed to the Government. "There is no conflict any more", says Gunnar Goude from the board of the Swedish Council for Planning and Coordinating Research (FRN), after reviewing the comprehensive documentation from the four seminars. "There is total agreement among the Board members that it is time to move forward and leave amalgam.
jay - 14 Jun 2007 05:55 GMT > amalgam fillings (total, 0.7-1.2 g) caused deposition of mercury in > the following tissues: spinal ganglia, anterior pituitary, adrenal, > medulla, liver, kidneys, lungs, and intestinal lymph glands. In > monkeys with maxillary silver amalgam implants (total, 0.1-0.3 g), > mercury was found in the same organs except for liver, lungs, and > intestinal lymph glands. Toxic effect of heavy metals on cells isolated from the rat adrenal and testis.
Ng TB, Liu WK. Department of Biochemistry, Faculty of Medicine, Chinese University of Hong Kong, Shatin.
Heavy metals including mercury, cadmium, cobalt, and copper (100 microM) exerted an adverse effect on the viability of isolated rat adrenal capsular (zona glomerulosa), adrenal decapsular (fasciculata and reticularis), and Leydig cells of the testis, with mercury being the most potent. Due to the decreased cell viability there was a parallel reduction in corticotropin-stimulated corticosterone production by adrenal decapsular cells and luteinizing hormone- stimulated testosterone production by Leydig cells. The results indicated a direct toxic action of these heavy metals on steroid- producing cells in the adrenal gland and the testis. Other metals tested, including lead, zinc, aluminum, chromium, iron, nickel, and lithium, did not exert any deleterious effect on cell viability or hormone-induced steroidogenesis in adrenal and Leydig cells when tested up to a concentration of 100 microM.
PMID: 2155192 [PubMed - indexed for MEDLINE]
|
|
|